Cover Image
市場調查報告書

勃起功能障礙 (ED):主要29個國家的市場預測

Epiomic Epidemiology Series: Erectile Dysfunction Forecast in 29 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 479876
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
勃起功能障礙 (ED):主要29個國家的市場預測 Epiomic Epidemiology Series: Erectile Dysfunction Forecast in 29 Major Markets 2017-2027
出版日期: 2017年03月01日 內容資訊: 英文 62 Pages
簡介

本報告提供全球主要29個國家的勃起功能障礙 (ED)的發病情形相關分析,疾病概要和目前的患病人數,各子類型及性別、各年代 (5歲劃分)的詳細情況,各地區、各民族趨勢,風險要素,疾病診斷預後,主要的症狀和併發症 (慢性心臟疾病,高血壓,糖尿病,前列腺肥大症 (BPH),貧血,憂鬱症,性慾衰退等),未來趨勢預測 (今後10年分) 的資訊彙整,為您概述為以下內容與。

目錄

  • 圖表一覽
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • 疾病相關的主要的共生病症/特徵
  • 患者數的測量方法
  • 勃起功能障礙 (ED)的最大患病人數
  • 勃起功能障礙的特徵
    • ED患者的共生病症
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

圖表一覽

分析觀察對象國家

  • 阿根廷
  • 澳洲
  • 巴西
  • 加拿大
  • 中國
  • 克羅埃西亞
  • 埃及
  • 法國
  • 德國
  • 希臘
  • 印度
  • 義大利
  • 日本
  • 墨西哥
  • 荷蘭
  • 挪威
  • 波蘭
  • 葡萄牙
  • 羅馬尼亞
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 韓國
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 英國
  • 美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: EDYS0010317

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Erectile Dysfunction in 29 Major Markets

Erectile dysfunction, also known as ED and impotence, is defined as the frequent inability to achieve or maintain an erection sufficient for sexual activity to take place.

This report provides the current prevalent population for Erectile Dysfunction across 29 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Netherlands, Portugal, Switzerland, Croatia, Poland, Romania, Russia, Norway, Sweden, Greece, Turkey, Saudi Arabia, Egypt, China, Japan, South Korea, India, Australia, South Africa, Brazil, Mexico, Argentina) split 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Erectile Dysfunction have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Erectile Dysfunction disease include:

  • Chronic heart disease
  • Hypertension
  • Diabetes
  • BPH
  • Anaemia
  • Depression
  • Loss of libido

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Erectile Dysfunction market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Erectile Dysfunction and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Erectile Dysfunction prevalent population.
  • Identify sub-populations within Erectile Dysfunction which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Erectile Dysfunction patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Erectile Dysfunction
  • Features of Erectile Dysfunction patients
    • Comorbid conditions of ED patients
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • IIEF-5 questionnaire
  • Prevalence of Erectile Dysfunction, malesl (000s)
  • Severity of ED, males (000s)
  • Smoking status of ED patients, males (000s)
  • Diagnosed with enlarged prostate, males (000s)
  • ED patients with diabetes, males (000s)
  • ED patients with depression, males (000s)
  • ED patients with hypertension, males (000s)
  • Cardiovascular disease, males (000s)
  • ED patients that are overweight (BMI ≥ 25), males (000s)
  • ED patients that are seeking treatment, males (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Canada Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • France Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Germany Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Italy Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Spain Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • UK Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Netherlands Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Portugal Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Switzerland Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Croatia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Poland Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Romania Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Russia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Norway Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Sweden Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Greece Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Turkey Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Saudi Arabia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Egypt Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • China Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Japan Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • South Korea Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • India Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Australia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • South Africa Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Mexico Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Argentina Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
Back to Top